On the other hand, TIMP3 was proved to function as a tumor‐suppressor by blocking the binding between VEGF and VEGFR [32] and modulating extracellular matrix (EM) production, an important player in angiogenesis [33]. The gene discussed is VEGFA; the disease is neoplasm.